US Stock MarketDetailed Quotes

SAGE Sage Therapeutics

Watchlist
  • 7.140
  • -0.040-0.56%
Close Feb 14 16:00 ET
  • 7.160
  • +0.020+0.28%
Post 20:01 ET
438.97MMarket Cap-1.08P/E (TTM)

Sage Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
50.57%-267.19M
44.31%-66.56M
39.38%-82.37M
38.84%-80.44M
75.38%-37.83M
-17.51%-540.59M
5.84%-119.52M
-14.30%-135.87M
-23.56%-131.52M
-42.56%-153.68M
Net income from continuing operations
26.01%-400.67M
-192.85%-95.78M
53.60%-93.55M
35.85%-102.85M
26.12%-108.48M
-1.63%-541.49M
77.77%-32.71M
-46.83%-201.63M
-26.98%-160.33M
-20.30%-146.83M
Operating gains losses
-160.61%-344K
-159.02%-158K
---51K
-166.67%-112K
20.69%-23K
91.20%-132K
-69.44%-61K
--0
84.15%-42K
97.56%-29K
Depreciation and amortization
-25.99%1.03M
-68.46%129K
-22.73%255K
-6.04%311K
4.02%336K
24.15%1.39M
41.03%409K
18.71%330K
18.64%331K
17.45%323K
Change In working capital
225.79%84.76M
119.53%20.76M
-102.83%-1.18M
-67.06%6.99M
342.40%58.19M
-1,288.22%-67.38M
-1,858.26%-106.29M
954.74%41.69M
719.15%21.22M
-247.07%-24.01M
-Change in receivables
206.53%73.88M
109.48%5.74M
33.61%-4.93M
743.18%566K
5,502.38%72.5M
-1,531.06%-69.35M
-1,363.49%-60.5M
-240.75%-7.42M
97.76%-88K
-3.95%-1.34M
-Change in prepaid assets
-25.92%14.08M
-34.69%1.88M
-21.55%9.11M
-117.20%-2.16M
165.27%5.24M
272.97%19M
31.45%2.88M
200.47%11.62M
394.87%12.53M
-404.52%-8.02M
-Change in payables and accrued expense
49.28%-7.29M
124.06%11.66M
-122.04%-8.25M
-23.28%8.92M
-31.31%-19.62M
-210.06%-14.36M
-5,421.87%-48.48M
258.89%37.43M
3.29%11.63M
-92.56%-14.94M
-Change in other current assets
110.01%9.02M
-8.87%1.47M
122.19%4.07M
237.19%1.55M
-2.62%1.93M
-15.07%4.3M
2.28%1.61M
30.06%1.83M
-206.39%-1.13M
96.53%1.99M
-Change in other current liabilities
29.32%-4.93M
100.39%7K
33.05%-1.18M
-10.24%-1.9M
-10.20%-1.86M
-10.65%-6.97M
-10.35%-1.8M
-10.34%-1.76M
-10.48%-1.72M
-11.50%-1.69M
Cash from discontinued investing activities
Operating cash flow
50.57%-267.19M
44.31%-66.56M
39.38%-82.37M
38.84%-80.44M
75.38%-37.83M
-17.51%-540.59M
5.84%-119.52M
-14.30%-135.87M
-23.56%-131.52M
-42.56%-153.68M
Investing cash flow
Cash flow from continuing investing activities
-39.79%266.68M
10.73%46.57M
-49.47%81.05M
-100.85%-386K
-28.45%139.44M
36.10%442.91M
-53.15%42.06M
44.56%160.39M
-66.04%45.59M
2,138.78%194.87M
Net PPE purchase and sale
--0
--0
--0
--0
--0
40.98%-553K
139.72%112K
9.89%-328K
8.20%-112K
-33.14%-225K
Net investment purchase and sale
-39.87%266.68M
11.03%46.57M
-49.57%81.05M
-100.84%-386K
-28.53%139.44M
35.88%443.47M
-53.42%41.95M
44.38%160.72M
-65.99%45.71M
2,177.88%195.09M
Cash from discontinued investing activities
Investing cash flow
-39.79%266.68M
10.73%46.57M
-49.47%81.05M
-100.85%-386K
-28.45%139.44M
36.10%442.91M
-53.15%42.06M
44.56%160.39M
-66.04%45.59M
2,138.78%194.87M
Financing cash flow
Cash flow from continuing financing activities
76.92%10.66M
99.24%-2K
-62.56%1.04M
852.89%8.07M
-41.73%1.56M
96.32%6.03M
-1,003.45%-262K
125.39%2.77M
6,415.38%847K
48.53%2.67M
Net common stock issuance
--8.16M
--0
--1K
----
----
--0
--0
--0
----
----
Proceeds from stock option exercised by employees
-56.44%3.02M
---1K
-48.27%1.44M
-96.96%26K
-52.77%1.56M
122.61%6.93M
--0
122.99%2.77M
2,210.81%855K
83.49%3.3M
Net other financing activities
42.41%-520K
99.62%-1K
-9,875.00%-399K
-1,375.00%-118K
99.68%-2K
-2,000.00%-903K
-6,450.00%-262K
73.33%-4K
---8K
---629K
Cash from discontinued financing activities
Financing cash flow
76.92%10.66M
99.24%-2K
-62.56%1.04M
852.89%8.07M
-41.73%1.56M
96.32%6.03M
-1,003.45%-262K
125.39%2.77M
6,415.38%847K
48.53%2.67M
Net cash flow
Beginning cash position
-55.89%72.32M
-31.71%102.46M
-16.31%102.73M
-15.56%175.49M
-55.89%72.32M
-44.51%163.97M
-25.39%150.04M
-40.92%122.75M
15.50%207.83M
-44.51%163.97M
Current changes in cash
111.07%10.15M
74.28%-19.99M
-101.00%-274K
14.49%-72.75M
135.22%103.16M
30.33%-91.65M
-109.34%-77.72M
508.38%27.3M
-405.64%-85.08M
137.95%43.86M
End cash Position
14.03%82.47M
14.03%82.47M
-31.71%102.46M
-16.31%102.73M
-15.56%175.49M
-55.89%72.32M
-55.89%72.32M
-25.39%150.04M
-40.92%122.75M
15.50%207.83M
Free cash flow
50.62%-267.19M
44.26%-66.56M
39.52%-82.37M
38.89%-80.44M
75.42%-37.83M
-17.39%-541.14M
6.14%-119.41M
-14.23%-136.19M
-23.53%-131.63M
-42.55%-153.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 50.57%-267.19M44.31%-66.56M39.38%-82.37M38.84%-80.44M75.38%-37.83M-17.51%-540.59M5.84%-119.52M-14.30%-135.87M-23.56%-131.52M-42.56%-153.68M
Net income from continuing operations 26.01%-400.67M-192.85%-95.78M53.60%-93.55M35.85%-102.85M26.12%-108.48M-1.63%-541.49M77.77%-32.71M-46.83%-201.63M-26.98%-160.33M-20.30%-146.83M
Operating gains losses -160.61%-344K-159.02%-158K---51K-166.67%-112K20.69%-23K91.20%-132K-69.44%-61K--084.15%-42K97.56%-29K
Depreciation and amortization -25.99%1.03M-68.46%129K-22.73%255K-6.04%311K4.02%336K24.15%1.39M41.03%409K18.71%330K18.64%331K17.45%323K
Change In working capital 225.79%84.76M119.53%20.76M-102.83%-1.18M-67.06%6.99M342.40%58.19M-1,288.22%-67.38M-1,858.26%-106.29M954.74%41.69M719.15%21.22M-247.07%-24.01M
-Change in receivables 206.53%73.88M109.48%5.74M33.61%-4.93M743.18%566K5,502.38%72.5M-1,531.06%-69.35M-1,363.49%-60.5M-240.75%-7.42M97.76%-88K-3.95%-1.34M
-Change in prepaid assets -25.92%14.08M-34.69%1.88M-21.55%9.11M-117.20%-2.16M165.27%5.24M272.97%19M31.45%2.88M200.47%11.62M394.87%12.53M-404.52%-8.02M
-Change in payables and accrued expense 49.28%-7.29M124.06%11.66M-122.04%-8.25M-23.28%8.92M-31.31%-19.62M-210.06%-14.36M-5,421.87%-48.48M258.89%37.43M3.29%11.63M-92.56%-14.94M
-Change in other current assets 110.01%9.02M-8.87%1.47M122.19%4.07M237.19%1.55M-2.62%1.93M-15.07%4.3M2.28%1.61M30.06%1.83M-206.39%-1.13M96.53%1.99M
-Change in other current liabilities 29.32%-4.93M100.39%7K33.05%-1.18M-10.24%-1.9M-10.20%-1.86M-10.65%-6.97M-10.35%-1.8M-10.34%-1.76M-10.48%-1.72M-11.50%-1.69M
Cash from discontinued investing activities
Operating cash flow 50.57%-267.19M44.31%-66.56M39.38%-82.37M38.84%-80.44M75.38%-37.83M-17.51%-540.59M5.84%-119.52M-14.30%-135.87M-23.56%-131.52M-42.56%-153.68M
Investing cash flow
Cash flow from continuing investing activities -39.79%266.68M10.73%46.57M-49.47%81.05M-100.85%-386K-28.45%139.44M36.10%442.91M-53.15%42.06M44.56%160.39M-66.04%45.59M2,138.78%194.87M
Net PPE purchase and sale --0--0--0--0--040.98%-553K139.72%112K9.89%-328K8.20%-112K-33.14%-225K
Net investment purchase and sale -39.87%266.68M11.03%46.57M-49.57%81.05M-100.84%-386K-28.53%139.44M35.88%443.47M-53.42%41.95M44.38%160.72M-65.99%45.71M2,177.88%195.09M
Cash from discontinued investing activities
Investing cash flow -39.79%266.68M10.73%46.57M-49.47%81.05M-100.85%-386K-28.45%139.44M36.10%442.91M-53.15%42.06M44.56%160.39M-66.04%45.59M2,138.78%194.87M
Financing cash flow
Cash flow from continuing financing activities 76.92%10.66M99.24%-2K-62.56%1.04M852.89%8.07M-41.73%1.56M96.32%6.03M-1,003.45%-262K125.39%2.77M6,415.38%847K48.53%2.67M
Net common stock issuance --8.16M--0--1K----------0--0--0--------
Proceeds from stock option exercised by employees -56.44%3.02M---1K-48.27%1.44M-96.96%26K-52.77%1.56M122.61%6.93M--0122.99%2.77M2,210.81%855K83.49%3.3M
Net other financing activities 42.41%-520K99.62%-1K-9,875.00%-399K-1,375.00%-118K99.68%-2K-2,000.00%-903K-6,450.00%-262K73.33%-4K---8K---629K
Cash from discontinued financing activities
Financing cash flow 76.92%10.66M99.24%-2K-62.56%1.04M852.89%8.07M-41.73%1.56M96.32%6.03M-1,003.45%-262K125.39%2.77M6,415.38%847K48.53%2.67M
Net cash flow
Beginning cash position -55.89%72.32M-31.71%102.46M-16.31%102.73M-15.56%175.49M-55.89%72.32M-44.51%163.97M-25.39%150.04M-40.92%122.75M15.50%207.83M-44.51%163.97M
Current changes in cash 111.07%10.15M74.28%-19.99M-101.00%-274K14.49%-72.75M135.22%103.16M30.33%-91.65M-109.34%-77.72M508.38%27.3M-405.64%-85.08M137.95%43.86M
End cash Position 14.03%82.47M14.03%82.47M-31.71%102.46M-16.31%102.73M-15.56%175.49M-55.89%72.32M-55.89%72.32M-25.39%150.04M-40.92%122.75M15.50%207.83M
Free cash flow 50.62%-267.19M44.26%-66.56M39.52%-82.37M38.89%-80.44M75.42%-37.83M-17.39%-541.14M6.14%-119.41M-14.23%-136.19M-23.53%-131.63M-42.55%-153.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
HNAC Technology
300490
+19.95%
5
Cubic Digital Technology
300344
+19.64%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call
Earnings Season Underway
Earnings season is here. What to know?